<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01//EN" "http://www.w3.org/TR/html4/strict.dtd">
<html xmlns:n1="urn:hl7-org:v3" xmlns:in="urn:lantana-com:inline-variable-data" xmlns:sdtc="urn:hl7-org:sdtc"><head>
<meta charset="utf-8"><!-- Do NOT edit this HTML directly: it was generated via an XSLT transformation from a CDA Release 2 XML document. --><title>Encounter Summary</title><style type="text/css">
body {
  color: #003366;
  background-color: #FFFFFF;
  font-family: Verdana, Tahoma, sans-serif;
  font-size: 14px;
}

a {
  color: #003366;
  background-color: #FFFFFF;
}

h1 {
  font-size: 20px;
  font-weight: bold;
}

h2 {
  font-size: 18px;
  font-weight: bold;
}

h3 {
  font-size: 14px;
  font-weight: bold;
}

h4 {
  font-size: 14px;
  font-weight: bold;
}


table {
  width: 100%;
}

th {
  background-color: #ffd700;
}

td {
  padding: 0.1cm 0.2cm;
  vertical-align: top;
  background-color: #ffffcc;
}

.h1center {
  font-size: 20px;
  font-weight: bold;
  text-align: center;
  width: 80%;
}

.header_table{
  border: 1pt inset #00008b;
}

.td_label{
  font-weight: bold;
  color: white;
}

.content_span{
 font-family: Verdana, Tahoma, sans-serif;
 display: inline;
 white-space: pre-line;
}

.td_header_role_name{
  width: 20%;
  background-color: #3399ff;
}

.td_header_role_value{
  width: 80%;
  background-color: #ccccff;
}

.Bold{
  font-weight: bold;
}

.Italics{
  font-style: italic;
}

.Underline{
  text-decoration:underline;
}

.internal_format
{
	list-style: none;
	list-style-position:outside;
	margin:0;
	padding:0;
	border:0;
	border-collapse: collapse;
}
          </style></head><body>
<h2><a name="toc">Table of Contents</a></h2><ul><li><a href="#id1">Reason for Visit</a></li><li><a href="#id2">Encounter Details</a></li><li><a href="#id3">Social History</a></li><li><a href="#id4">Last Filed Vital Signs</a></li><li><a href="#id5">Progress Notes</a></li><li><a href="#id6">Plan of Treatment</a></li><li><a href="#id7">Procedures</a></li><li><a href="#id8">Results</a></li><li><a href="#id9">Visit Diagnoses</a></li><li><a href="#id10">Additional Health Concerns</a></li><li><a href="#id11">Care Teams</a></li></ul><hr align="left" color="teal" size="2"/><h3><a name="id1" href="#toc">Reason for Visit</a></h3><div><ul><li><table><colgroup><col width="25%"/><col width="75%"/></colgroup><thead><tr><th>Reason</th><th>Comments</th></tr></thead><tbody><tr ID="rfv2"><td ID="reasonrfv2">Follow-up</td><td ID="rfv2comments">Prostate ca</td></tr></tbody></table></li></ul></div><h3><a name="id2" href="#toc">Encounter Details</a></h3><div><table><colgroup><col width="10%"/><col width="15%"/><col width="25%" span="3"/></colgroup><thead><tr><th>Date</th><th>Type</th><th>Department</th><th>Care Team (Latest Contact Info)</th><th>Description</th></tr></thead><tbody><tr ID="encounter3" class="xRowNormal"><td>[REDACTED]  8:20 AM EST</td><td ID="encounter3type">Office Visit</td><td><p>HCMG Cancer Center Hematology Oncology</p><p>[REDACTED]</p><p>[REDACTED][REDACTED]</p><p>[REDACTED]</p></td><td><p>[REDACTED], MD</p><p>[REDACTED]</p><p>[REDACTED], FL 33308</p><p>[REDACTED] (Work)</p><p>[REDACTED] (Fax)</p></td><td><content>Malignant neoplasm of prostate (CMS/HCC) (Primary Dx); <br/>History of muscular dystrophy</content></td></tr></tbody></table></div><h3><a name="id3" href="#toc">Social History</a></h3><div><table ID="sochist9"><colgroup><col width="25%" span="2"/><col width="13%"/><col width="12%"/><col width="25%"/></colgroup><thead><tr><th>Tobacco Use</th><th>Types</th><th>Packs/Day</th><th>Years Used</th><th>Date</th></tr></thead><tbody><tr><td>Smoking Tobacco: Never</td><td/><td ID="sochist9packsperday"/><td/><td/></tr></tbody></table><table><tbody><tr><td ID="sochist9cessation" class="xnoIndent"><span class="xcellHeader">Tobacco Cessation:</span> Counseling Given: Not Answered<br/></td></tr></tbody></table><table><colgroup><col width="25%" span="2"/><col width="50%"/></colgroup><thead><tr><th>Alcohol Use</th><th>Standard Drinks/Week</th><th>Comments</th></tr></thead><tbody><tr><td ID="alcoholStatus">Yes</td><td>0 (1 standard drink = 0.6 oz pure alcohol)</td><td/></tr></tbody></table><table ID="sdohassess1"><colgroup><col width="50%"/><col width="25%" span="2"/></colgroup><thead><tr><th>Housing Instability</th><th>Answer</th><th>Date Recorded</th></tr></thead><tbody><tr ID="sdohassess1pair1"><td ID="sdohassess1pair1ques">Are you worried that in the next 2 months you may not have stable housing?</td><td ID="sdohassess1pair1ans">No</td><td>[REDACTED]</td></tr></tbody></table><table ID="sdohassess2"><colgroup><col width="50%"/><col width="25%" span="2"/></colgroup><thead><tr><th>Food Access &amp; Nutrition</th><th>Answer</th><th>Date Recorded</th></tr></thead><tbody><tr ID="sdohassess2pair1"><td ID="sdohassess2pair1ques">Do you have access to a variety of food including fruits and vegetables?</td><td ID="sdohassess2pair1ans">Yes</td><td>[REDACTED]</td></tr></tbody></table><table ID="sdohassess3"><colgroup><col width="50%"/><col width="25%" span="2"/></colgroup><thead><tr><th>Access to Healthcare</th><th>Answer</th><th>Date Recorded</th></tr></thead><tbody><tr ID="sdohassess3pair1"><td ID="sdohassess3pair1ques">Within the last 3 months, how many times did you visit the emergency department for your medical care?</td><td ID="sdohassess3pair1ans">1</td><td>[REDACTED]</td></tr></tbody></table><table ID="sdohassess4"><colgroup><col width="50%"/><col width="25%" span="2"/></colgroup><thead><tr><th>Health Literacy</th><th>Answer</th><th>Date Recorded</th></tr></thead><tbody><tr ID="sdohassess4pair1"><td ID="sdohassess4pair1ques">How often do you need to have someone help you when you read instructions, pamphlets, or other written material from your doctor or pharmacy?</td><td ID="sdohassess4pair1ans">Never</td><td>[REDACTED]</td></tr><tr ID="sdohassess4pair2"><td ID="sdohassess4pair2ques">Caregiver: How often do you need to have someone help you when you read instructions, pamphlets, or other written material from your doctor or pharmacy?</td><td ID="sdohassess4pair2ans">Not on file</td><td>[REDACTED]</td></tr></tbody></table><table ID="sdohassess5"><colgroup><col width="50%"/><col width="25%" span="2"/></colgroup><thead><tr><th>Financial Risk</th><th>Answer</th><th>Date Recorded</th></tr></thead><tbody><tr ID="sdohassess5pair1"><td ID="sdohassess5pair1ques">How hard is it for you to pay for the very basics like food, housing, medical care, and air conditioning / heating?</td><td ID="sdohassess5pair1ans">Not very hard</td><td>[REDACTED]</td></tr></tbody></table><table ID="sdohassess6"><colgroup><col width="50%"/><col width="25%" span="2"/></colgroup><thead><tr><th>Transportation</th><th>Answer</th><th>Date Recorded</th></tr></thead><tbody><tr ID="sdohassess6pair1"><td ID="sdohassess6pair1ques">Has the lack of transportation kept you from meetings, work, or from getting things needed for daily living?</td><td ID="sdohassess6pair1ans">No</td><td>[REDACTED]</td></tr><tr ID="sdohassess6pair2"><td ID="sdohassess6pair2ques">Has the lack of transportation kept you from medical appointments or from getting medications?</td><td ID="sdohassess6pair2ans">No</td><td>[REDACTED]</td></tr></tbody></table><table ID="sdohassess7"><colgroup><col width="50%"/><col width="25%" span="2"/></colgroup><thead><tr><th>Social Isolation</th><th>Answer</th><th>Date Recorded</th></tr></thead><tbody><tr ID="sdohassess7pair1"><td ID="sdohassess7pair1ques">How often do you feel lonely or isolated from those around you?</td><td ID="sdohassess7pair1ans">Never</td><td>[REDACTED]</td></tr></tbody></table><table ID="sdohassess8"><colgroup><col width="50%"/><col width="25%" span="2"/></colgroup><thead><tr><th>Food Risk</th><th>Answer</th><th>Date Recorded</th></tr></thead><tbody><tr ID="sdohassess8pair1"><td ID="sdohassess8pair1ques">Within the past 12 months we worried whether our food would run out before we got money to buy more.</td><td ID="sdohassess8pair1ans">Never true</td><td>[REDACTED]</td></tr><tr ID="sdohassess8pair2"><td ID="sdohassess8pair2ques">Within the past 12 months the food we bought just didn't last and we didn't have money to get more.</td><td ID="sdohassess8pair2ans">Never true</td><td>[REDACTED]</td></tr></tbody></table><table><colgroup><col width="50%"/><col width="25%" span="2"/></colgroup><thead><tr><th>Sex and Gender Information</th><th>Value</th><th>Date Recorded</th></tr></thead><tbody><tr ID="BirthSex12"><td>Sex Assigned at Birth</td><td ID="BirthSex12Value">Male</td><td>[REDACTED]  2:52 PM EDT</td></tr><tr ID="GenderIdentity10"><td>Gender Identity</td><td ID="GenderIdentity10Value">Male</td><td>[REDACTED]  2:52 PM EDT</td></tr><tr ID="SexualOrientation11"><td>Sexual Orientation</td><td ID="SexualOrientation11Value">Straight</td><td>[REDACTED]  2:53 PM EDT</td></tr></tbody></table><table><colgroup><col width="25%" span="2"/><col width="50%"/></colgroup><thead><tr><th>Job Start Date</th><th>Occupation</th><th>Industry</th></tr></thead><tbody><tr><td>Not on file</td><td ID="sochist13">Not on file</td><td ID="sochist14">Not on file</td></tr></tbody></table>documented as of this encounter</div><h3><a name="id4" href="#toc">Last Filed Vital Signs</a></h3><div><table><colgroup><col width="25%" span="4"/></colgroup><thead><tr><th>Vital Sign</th><th>Reading</th><th>Time Taken</th><th>Comments</th></tr></thead><tbody><tr class="xRowNormal"><td class="xcellHeader">Blood Pressure</td><td><span class="content_span">153</span>/<span class="content_span">85</span></td><td>[REDACTED]  8:37 AM EST</td><td/></tr><tr ID="pulse_5807338620" class="xRowAlt"><td class="xcellHeader">Pulse</td><td>70</td><td>[REDACTED]  8:37 AM EST</td><td/></tr><tr ID="temp_5807338620" class="xRowNormal"><td class="xcellHeader">Temperature</td><td>36.2 °C (97.2 °F)</td><td>[REDACTED]  8:37 AM EST</td><td/></tr><tr ID="resp_5807338620" class="xRowAlt"><td class="xcellHeader">Respiratory Rate</td><td>16</td><td>[REDACTED]  8:37 AM EST</td><td/></tr><tr ID="SpO2_5807338620" class="xRowNormal"><td class="xcellHeader">Oxygen Saturation</td><td>98%</td><td>[REDACTED]  8:37 AM EST</td><td/></tr><tr ID="inhaled_" class="xRowAlt"><td class="xcellHeader">Inhaled Oxygen Concentration</td><td>-</td><td>-</td><td/></tr><tr ID="weight_5807338620" class="xRowNormal"><td class="xcellHeader">Weight</td><td>74.8 kg (165 lb)</td><td>[REDACTED]  8:37 AM EST</td><td/></tr><tr ID="height_5807338620" class="xRowAlt"><td class="xcellHeader">Height</td><td>171.5 cm (5' 7.5")</td><td>[REDACTED]  8:37 AM EST</td><td/></tr><tr ID="bmi_5807338620" class="xRowNormal"><td class="xcellHeader">Body Mass Index</td><td>25.46</td><td>[REDACTED]  8:37 AM EST</td><td/></tr></tbody></table>documented in this encounter</div><h3><a name="id5" href="#toc">Progress Notes</a></h3><div><ul><li>[REDACTED], MD - [REDACTED]  8:20 AM EST: <content><content><span class="xLabel">Formatting of this note is different from the original.</span><br/>FOLLOW UP EVALUATION<br/>Hematology-Oncology<br/> <br/>[REDACTED]<br/>MRN: [REDACTED]<br/>Encounter Date: [REDACTED]<br/>PCP: [REDACTED], DO<br/> <br/> <br/>Encounter Diagnosis:<br/>1. Malignant neoplasm of prostate (CMS/HCC)  <br/>2. History of muscular dystrophy  <br/><br/>  <br/>HPI:<br/>[REDACTED] is a [REDACTED]. male, patient of [REDACTED] with prostate ca.<br/>[REDACTED] prostate biopsy revealed involvement by [REDACTED] 7 (3+4) prostate carcinoma involving 10% in the right apex, 20% in the right mid, [REDACTED] 6 (3+3) in the left lateral base, and otherwise benign tissue.<br/>[REDACTED] PSA 4.5.<br/>[REDACTED] da Vinci radical prostatectomy with bilateral pelvic lymph node biopsy reported bilateral prostate adenocarcinoma, [REDACTED] 7 (4+3), clear margins (closest margin 0.1 cm), perineural invasion and extracapsular invasion were present, lymph nodes were benign.<br/>[REDACTED] postoperative PSA &lt;0.1<br/>[REDACTED] PSA 1.56<br/>[REDACTED] PSA 1.66<br/>[REDACTED] CBC and CMP were unremarkable, PSA 2.35, testosterone 212<br/>[REDACTED] MRI of pelvis reported absent prostate, no residual or recurrent mass in prostate bed, bladder wall thickening, no evidence of pelvic sidewall lymphadenopathy.<br/>[REDACTED] PET/CT reported no FDG avid malignancy.<br/>[REDACTED] PSA 2.76<br/>[REDACTED] bone scan revealed no convincing metastatic disease to the bones, multilevel degenerative lumbar spine and upper left cervical spine, no prior bone scan for comparison.<br/><br/>[REDACTED] PSA 2.38<br/><br/> <br/>[REDACTED] patient had another fall with tibial fracture.  PSA remains low.  Will continue to monitor no Lupron to be given [REDACTED].<br/><br/>Past Medical History: <br/>Diagnosis Date <br/> Difficulty walking  <br/> History of muscular dystrophy  <br/> Hyperlipidemia  <br/> Hypertension  <br/> <br/> <br/>No past surgical history on file.<br/> <br/>Family History <br/>Problem Relation Name Age of Onset <br/> Emphysema Father   <br/><br/> <br/>Social History <br/><br/>Socioeconomic History <br/> Marital status: Married <br/>  Spouse name: Not on file <br/> Number of children: Not on file <br/> Years of education: Not on file <br/> Highest education level: Not on file <br/>Occupational History <br/> Not on file <br/>Tobacco Use <br/> Smoking status: Never <br/> Smokeless tobacco: Not on file <br/>Substance and Sexual Activity <br/> Alcohol use: Yes <br/> Drug use: Not on file <br/> Sexual activity: Not on file <br/>Other Topics Concern <br/> Not on file <br/>Social History Narrative <br/> Not on file <br/><br/> <br/>Home Medication(s):<br/><br/>Current Outpatient Medications: <br/>  aspirin 81 mg EC tablet, Take 1 tablet (81 mg total) by mouth 1 (one) time each day., Disp: , Rfl: <br/>  leuprolide (LUPRON) 11.25 mg injection, Inject 11.25 mg into the shoulder, thigh, or buttocks every 3 (three) months., Disp: , Rfl: <br/>  lisinopril-hydroCHLOROthiazide (PRINZIDE,ZESTORETIC) 20-25 mg per tablet, , Disp: , Rfl: <br/>  rosuvastatin (CRESTOR) 20 mg tablet, , Disp: , Rfl: <br/> <br/>Allergies:<br/>No Known Allergies<br/> <br/>Physical Exam:<br/>Vitals: <br/> [REDACTED] 0837 <br/>BP: (!) 153/85 <br/>BP Location: Left arm <br/>Patient Position: Sitting <br/>BP Cuff Size: Large adult <br/>Pulse: 70 <br/>Resp: 16 <br/>Temp: 36.2 °C (97.2 °F) <br/>TempSrc: Skin <br/>SpO2: 98% <br/>Weight: 74.8 kg (165 lb) <br/>Height: 1.715 m (67.5") <br/><br/>No data recorded<br/> <br/>ECOG 0<br/>General: no apparent distress, appears stated age<br/>Head/Neck/Throat: normocephalic, moist mucous membranes<br/>Eyes: sclera anicteric<br/>Thorax: equal expansion with normal work of breathing<br/>Musculoskeletal: no gross deformities<br/>Neurologic: alert/awake/oriented, grossly no abnormalities<br/><br/>Labs Reviewed:<br/>Lab Results <br/>Component Value Date <br/> WBC 6.1 [REDACTED] <br/> HGB 12.9 (L) [REDACTED] <br/> HCT 37.4 (L) [REDACTED] <br/> MCV 87.0 [REDACTED] <br/> PLT 240 [REDACTED] <br/><br/>Lab Results <br/>Component Value Date <br/> NA 142 [REDACTED] <br/> K 4.4 [REDACTED] <br/> CL 105 [REDACTED] <br/> CO2 30 [REDACTED] <br/> GLUCOSE 107 [REDACTED] <br/> BUN 16 [REDACTED] <br/> CREATININE 0.37 (L) [REDACTED] <br/> CALCIUM 10.0 [REDACTED] <br/> PROT 7.1 [REDACTED] <br/> ALBUMIN 4.3 [REDACTED] <br/> BILITOT 0.5 [REDACTED] <br/> AST 41 (H) [REDACTED] <br/> ALT 55 (H) [REDACTED] <br/> ALKPHOS 77 [REDACTED] <br/> EGFR 116 [REDACTED] <br/><br/>Lab Results <br/>Component Value Date <br/> PSA 0.03 [REDACTED] <br/> PSA &lt;0.01 (L) [REDACTED] <br/> PSA &lt;33.3 [REDACTED] <br/> PSA 0.04 [REDACTED] <br/> PSA 0.04 [REDACTED] <br/> PSA 3.57 [REDACTED] <br/> <br/>Diagnostics:<br/>N/A<br/> <br/>Assessment and Plan:<br/>[REDACTED] is a [REDACTED]. male with prostate carcinoma as noted above, status post radical prostatectomy, has not followed with urologist as recommended.  His PSA was monitored by PCP.<br/><br/>PSA only relapse<br/>Continue intermittent ADT<br/>Will hold [REDACTED]<br/>Previously held due to exacerbation of muscular dystrophy muscle weakness<br/>Monitor PSA <br/><br/>Noted elevated blood pressure<br/>Patient will follow-up with PCP for hypertension management<br/> <br/>The patient was offered a follow-up visit [REDACTED]<br/> <br/>No orders of the defined types were placed in this encounter.<br/><br/>Requested Prescriptions <br/><br/> No prescriptions requested or ordered in this encounter <br/> <br/>Plan of care and medications have been reviewed with the patient who has verbalized understanding.<br/>The patient understands that he is responsible to follow-up as scheduled, and should not assume the performed studies are normal until their results are discussed with me or other provider.<br/><br/> <br/>[REDACTED], MD <br/>[REDACTED]<br/> <br/></content><br/><span class="xLabel">Electronically signed by [REDACTED], MD at [REDACTED]  9:09 AM EST</span><br/></content></li></ul>documented in this encounter</div><h3><a name="id6" href="#toc">Plan of Treatment</a></h3><div><table><span style="font-weight:bold; ">Upcoming Encounters</span><colgroup><col width="10%"/><col width="15%"/><col width="25%" span="3"/></colgroup><thead><tr><th>Date</th><th>Type</th><th>Department</th><th>Care Team (Latest Contact Info)</th><th>Description</th></tr></thead><tbody><tr ID="encounter34" class="xRowNormal"><td>[REDACTED]  8:40 AM EDT</td><td ID="encounter34type">Office Visit</td><td><p>HCMG Cancer Center Hematology Oncology</p><p>[REDACTED]</p><p>[REDACTED][REDACTED]</p><p>[REDACTED]</p></td><td><p>[REDACTED], MD</p><p>[REDACTED]</p><p>[REDACTED]</p><p>[REDACTED] (Work)</p><p>[REDACTED] (Fax)</p></td><td/></tr></tbody></table>documented as of this encounter</div><h3><a name="id7" href="#toc">Procedures</a></h3><div><table><colgroup><col width="25%"/><col width="10%"/><col width="15%"/><col width="25%" span="2"/></colgroup><thead><tr><th>Procedure Name</th><th>Priority</th><th>Date/Time</th><th>Associated Diagnosis</th><th>Comments</th></tr></thead><tbody><tr ID="procedure43" class="xRowNormal"><td><span class="content_span">CBC WITH AUTO DIFFERENTIAL</span></td><td>Routine</td><td>[REDACTED]  9:10 AM EST</td><td><p>Malignant neoplasm of prostate (CMS/HCC)</p><p>History of muscular dystrophy</p></td><td><p>Results for this procedure are in the <span class="xLink2-Result.1.2.840.114350.1.13.502.2.7.2.798268.1291111714">results section</span>.</p></td></tr><tr ID="procedure42" class="xRowAlt"><td><span class="content_span">CBC AND DIFFERENTIAL</span></td><td>Routine</td><td>[REDACTED]  9:10 AM EST</td><td><p>Malignant neoplasm of prostate (CMS/HCC)</p><p>History of muscular dystrophy</p></td><td><p>Results for this procedure are in the <span class="xLink2-Result.1.2.840.114350.1.13.502.2.7.2.798268.1291111713">results section</span>.</p></td></tr><tr ID="procedure41" class="xRowNormal"><td><span class="content_span">PROSTATE SPECIFIC ANTIGEN TOTAL AND FREE</span></td><td>Routine</td><td>[REDACTED]  9:10 AM EST</td><td><p>Malignant neoplasm of prostate (CMS/HCC)</p><p>History of muscular dystrophy</p></td><td><p>Results for this procedure are in the <span class="xLink2-Result.1.2.840.114350.1.13.502.2.7.2.798268.1291111710">results section</span>.</p></td></tr><tr ID="procedure40" class="xRowAlt"><td><span class="content_span">TESTOSTERONE, TOTAL</span></td><td>Routine</td><td>[REDACTED]  9:10 AM EST</td><td><p>Malignant neoplasm of prostate (CMS/HCC)</p><p>History of muscular dystrophy</p></td><td><p>Results for this procedure are in the <span class="xLink2-Result.1.2.840.114350.1.13.502.2.7.2.798268.1291111711">results section</span>.</p></td></tr><tr ID="procedure39" class="xRowNormal"><td><span class="content_span">COMPREHENSIVE METABOLIC PANEL</span></td><td>Routine</td><td>[REDACTED]  9:10 AM EST</td><td><p>Malignant neoplasm of prostate (CMS/HCC)</p><p>History of muscular dystrophy</p></td><td><p>Results for this procedure are in the <span class="xLink2-Result.1.2.840.114350.1.13.502.2.7.2.798268.1291111712">results section</span>.</p></td></tr></tbody></table>documented in this encounter</div><h3><a name="id8" href="#toc">Results</a></h3><div><ul><li>(ABNORMAL) CBC auto differential ([REDACTED]  9:10 AM EST): <table><colgroup><col width="20%"/><col width="12%"/><col width="8%"/><col width="20%"/><col width="10%" span="2"/><col width="20%"/></colgroup><thead><tr><th>Component</th><th>Value</th><th>Ref Range</th><th>Test Method</th><th>Analysis Time</th><th>Performed At</th><th>Pathologist Signature</th></tr></thead><tbody><tr ID="Result.1.2.840.114350.1.13.502.2.7.2.798268.1291111714.Comp1" class="xRowNormal"><td ID="Result.1.2.840.114350.1.13.502.2.7.2.798268.1291111714.Comp1Name">WBC</td><td>5.2</td><td>4.5 - 11.0 K/mcL</td><td><p>LAB HEMETOLOGY METHOD</p></td><td>[REDACTED] 10:01 AM EST</td><td>HOLY CROSS [REDACTED] FL (HCFL) HOSPITAL LAB</td><td ID="Result.1.2.840.114350.1.13.502.2.7.2.798268.1291111714.Comp1Signature"/></tr><tr ID="Result.1.2.840.114350.1.13.502.2.7.2.798268.1291111714.Comp2" class="xRowAlt"><td ID="Result.1.2.840.114350.1.13.502.2.7.2.798268.1291111714.Comp2Name">RBC</td><td><span class="xflagData">4.14</span><span class="xflagData"> (L)</span></td><td>4.30 - 6.20 M/mcL</td><td><p>LAB HEMETOLOGY METHOD</p></td><td>[REDACTED] 10:01 AM EST</td><td>HOLY CROSS [REDACTED] FL (HCFL) HOSPITAL LAB</td><td ID="Result.1.2.840.114350.1.13.502.2.7.2.798268.1291111714.Comp2Signature"/></tr><tr ID="Result.1.2.840.114350.1.13.502.2.7.2.798268.1291111714.Comp3" class="xRowNormal"><td ID="Result.1.2.840.114350.1.13.502.2.7.2.798268.1291111714.Comp3Name">Hemoglobin</td><td><span class="xflagData">11.9</span><span class="xflagData"> (L)</span></td><td>14.0 - 18.0 g/dL</td><td><p>LAB HEMETOLOGY METHOD</p></td><td>[REDACTED] 10:01 AM EST</td><td>[REDACTED] (HCFL) HOSPITAL LAB</td><td ID="Result.1.2.840.114350.1.13.502.2.7.2.798268.1291111714.Comp3Signature"/></tr><tr ID="Result.1.2.840.114350.1.13.502.2.7.2.798268.1291111714.Comp4" class="xRowAlt"><td ID="Result.1.2.840.114350.1.13.502.2.7.2.798268.1291111714.Comp4Name">Hematocrit</td><td><span class="xflagData">36.5</span><span class="xflagData"> (L)</span></td><td>39.0 - 55.0 %</td><td><p>LAB HEMETOLOGY METHOD</p></td><td>[REDACTED] 10:01 AM EST</td><td>HOLY CROSS [REDACTED] FL (HCFL) HOSPITAL LAB</td><td ID="Result.1.2.840.114350.1.13.502.2.7.2.798268.1291111714.Comp4Signature"/></tr><tr ID="Result.1.2.840.114350.1.13.502.2.7.2.798268.1291111714.Comp5" class="xRowNormal"><td ID="Result.1.2.840.114350.1.13.502.2.7.2.798268.1291111714.Comp5Name">MCV</td><td>88.2</td><td>80.0 - 100.0 FL</td><td><p>LAB HEMETOLOGY METHOD</p></td><td>[REDACTED] 10:01 AM EST</td><td>[REDACTED] FL (HCFL) HOSPITAL LAB</td><td ID="Result.1.2.840.114350.1.13.502.2.7.2.798268.1291111714.Comp5Signature"/></tr><tr ID="Result.1.2.840.114350.1.13.502.2.7.2.798268.1291111714.Comp6" class="xRowAlt"><td ID="Result.1.2.840.114350.1.13.502.2.7.2.798268.1291111714.Comp6Name">MCH</td><td>28.8</td><td>27.0 - 34.0 pcg</td><td><p>LAB HEMETOLOGY METHOD</p></td><td>[REDACTED] 10:01 AM EST</td><td>HOLY CROSS [REDACTED] FL (HCFL) HOSPITAL LAB</td><td ID="Result.1.2.840.114350.1.13.502.2.7.2.798268.1291111714.Comp6Signature"/></tr><tr ID="Result.1.2.840.114350.1.13.502.2.7.2.798268.1291111714.Comp7" class="xRowNormal"><td ID="Result.1.2.840.114350.1.13.502.2.7.2.798268.1291111714.Comp7Name">MCHC</td><td>32.6</td><td>31.0 - 37.0 g/dL</td><td><p>LAB HEMETOLOGY METHOD</p></td><td>[REDACTED] 10:01 AM EST</td><td>HOLY CROSS [REDACTED] FL (HCFL) HOSPITAL LAB</td><td ID="Result.1.2.840.114350.1.13.502.2.7.2.798268.1291111714.Comp7Signature"/></tr><tr ID="Result.1.2.840.114350.1.13.502.2.7.2.798268.1291111714.Comp8" class="xRowAlt"><td ID="Result.1.2.840.114350.1.13.502.2.7.2.798268.1291111714.Comp8Name">RDW</td><td>14.5</td><td>12.0 - 15.0 %</td><td><p>LAB HEMETOLOGY METHOD</p></td><td>[REDACTED] 10:01 AM EST</td><td>[REDACTED] FL (HCFL) HOSPITAL LAB</td><td ID="Result.1.2.840.114350.1.13.502.2.7.2.798268.1291111714.Comp8Signature"/></tr><tr ID="Result.1.2.840.114350.1.13.502.2.7.2.798268.1291111714.Comp9" class="xRowNormal"><td ID="Result.1.2.840.114350.1.13.502.2.7.2.798268.1291111714.Comp9Name">Platelets</td><td>238</td><td>130 - 400 K/mcL</td><td><p>LAB HEMETOLOGY METHOD</p></td><td>[REDACTED] 10:01 AM EST</td><td>HOLY CROSS [REDACTED] FL (HCFL) HOSPITAL LAB</td><td ID="Result.1.2.840.114350.1.13.502.2.7.2.798268.1291111714.Comp9Signature"/></tr><tr ID="Result.1.2.840.114350.1.13.502.2.7.2.798268.1291111714.Comp10" class="xRowAlt"><td ID="Result.1.2.840.114350.1.13.502.2.7.2.798268.1291111714.Comp10Name">MPV</td><td>7.7</td><td>6.2 - 12.1 FL</td><td><p>LAB HEMETOLOGY METHOD</p></td><td>[REDACTED] 10:01 AM EST</td><td>HOLY CROSS [REDACTED] FL (HCFL) HOSPITAL LAB</td><td ID="Result.1.2.840.114350.1.13.502.2.7.2.798268.1291111714.Comp10Signature"/></tr><tr ID="Result.1.2.840.114350.1.13.502.2.7.2.798268.1291111714.Comp11" class="xRowNormal"><td ID="Result.1.2.840.114350.1.13.502.2.7.2.798268.1291111714.Comp11Name">Neutrophils Relative</td><td>62.6</td><td>40.0 - 65.0 %</td><td><p>LAB HEMETOLOGY METHOD</p></td><td>[REDACTED] 10:01 AM EST</td><td>HOLY CROSS [REDACTED] FL (HCFL) HOSPITAL LAB</td><td ID="Result.1.2.840.114350.1.13.502.2.7.2.798268.1291111714.Comp11Signature"/></tr><tr ID="Result.1.2.840.114350.1.13.502.2.7.2.798268.1291111714.Comp12" class="xRowAlt"><td ID="Result.1.2.840.114350.1.13.502.2.7.2.798268.1291111714.Comp12Name">Lymphocytes Relative</td><td>24.2</td><td>15.0 - 40.0 %</td><td><p>LAB HEMETOLOGY METHOD</p></td><td>[REDACTED] 10:01 AM EST</td><td>[REDACTED] FL (HCFL) HOSPITAL LAB</td><td ID="Result.1.2.840.114350.1.13.502.2.7.2.798268.1291111714.Comp12Signature"/></tr><tr ID="Result.1.2.840.114350.1.13.502.2.7.2.798268.1291111714.Comp13" class="xRowNormal"><td ID="Result.1.2.840.114350.1.13.502.2.7.2.798268.1291111714.Comp13Name">Monocytes Relative</td><td>9.1</td><td>1.0 - 10.0 %</td><td><p>LAB HEMETOLOGY METHOD</p></td><td>[REDACTED] 10:01 AM EST</td><td>HOLY CROSS [REDACTED] FL (HCFL) HOSPITAL LAB</td><td ID="Result.1.2.840.114350.1.13.502.2.7.2.798268.1291111714.Comp13Signature"/></tr><tr ID="Result.1.2.840.114350.1.13.502.2.7.2.798268.1291111714.Comp14" class="xRowAlt"><td ID="Result.1.2.840.114350.1.13.502.2.7.2.798268.1291111714.Comp14Name">Eosinophils Relative</td><td>3.3</td><td>0.0 - 4.0 %</td><td><p>LAB HEMETOLOGY METHOD</p></td><td>[REDACTED] 10:01 AM EST</td><td>HOLY CROSS [REDACTED] FL (HCFL) HOSPITAL LAB</td><td ID="Result.1.2.840.114350.1.13.502.2.7.2.798268.1291111714.Comp14Signature"/></tr><tr ID="Result.1.2.840.114350.1.13.502.2.7.2.798268.1291111714.Comp15" class="xRowNormal"><td ID="Result.1.2.840.114350.1.13.502.2.7.2.798268.1291111714.Comp15Name">Basophils Relative</td><td>0.8</td><td>0.0 - 2.0 %</td><td><p>LAB HEMETOLOGY METHOD</p></td><td>[REDACTED] 10:01 AM EST</td><td>HOLY CROSS [REDACTED] FL (HCFL) HOSPITAL LAB</td><td ID="Result.1.2.840.114350.1.13.502.2.7.2.798268.1291111714.Comp15Signature"/></tr><tr ID="Result.1.2.840.114350.1.13.502.2.7.2.798268.1291111714.Comp16" class="xRowAlt"><td ID="Result.1.2.840.114350.1.13.502.2.7.2.798268.1291111714.Comp16Name">Neutrophils Absolute</td><td>3.30</td><td>1.80 - 7.70 K/mcL</td><td><p>LAB HEMETOLOGY METHOD</p></td><td>[REDACTED] 10:01 AM EST</td><td>[REDACTED] FL (HCFL) HOSPITAL LAB</td><td ID="Result.1.2.840.114350.1.13.502.2.7.2.798268.1291111714.Comp16Signature"/></tr><tr ID="Result.1.2.840.114350.1.13.502.2.7.2.798268.1291111714.Comp17" class="xRowNormal"><td ID="Result.1.2.840.114350.1.13.502.2.7.2.798268.1291111714.Comp17Name">Lymphocytes Absolute</td><td>1.30</td><td>1.00 - 4.00 K/mcL</td><td><p>LAB HEMETOLOGY METHOD</p></td><td>[REDACTED] 10:01 AM EST</td><td>HOLY CROSS [REDACTED] FL (HCFL) HOSPITAL LAB</td><td ID="Result.1.2.840.114350.1.13.502.2.7.2.798268.1291111714.Comp17Signature"/></tr><tr ID="Result.1.2.840.114350.1.13.502.2.7.2.798268.1291111714.Comp18" class="xRowAlt"><td ID="Result.1.2.840.114350.1.13.502.2.7.2.798268.1291111714.Comp18Name">Monocytes Absolute</td><td>0.50</td><td>0.20 - 1.00 K/mcL</td><td><p>LAB HEMETOLOGY METHOD</p></td><td>[REDACTED] 10:01 AM EST</td><td>HOLY CROSS [REDACTED] FL (HCFL) HOSPITAL LAB</td><td ID="Result.1.2.840.114350.1.13.502.2.7.2.798268.1291111714.Comp18Signature"/></tr><tr ID="Result.1.2.840.114350.1.13.502.2.7.2.798268.1291111714.Comp19" class="xRowNormal"><td ID="Result.1.2.840.114350.1.13.502.2.7.2.798268.1291111714.Comp19Name">Eosinophils Absolute</td><td>0.20</td><td>0.00 - 0.69 K/mcL</td><td><p>LAB HEMETOLOGY METHOD</p></td><td>[REDACTED] 10:01 AM EST</td><td>HOLY CROSS [REDACTED] FL (HCFL) HOSPITAL LAB</td><td ID="Result.1.2.840.114350.1.13.502.2.7.2.798268.1291111714.Comp19Signature"/></tr><tr ID="Result.1.2.840.114350.1.13.502.2.7.2.798268.1291111714.Comp20" class="xRowAlt"><td ID="Result.1.2.840.114350.1.13.502.2.7.2.798268.1291111714.Comp20Name">Basophils Absolute</td><td>0.00</td><td>0.00 - 0.19 K/mcL</td><td><p>LAB HEMETOLOGY METHOD</p></td><td>[REDACTED] 10:01 AM EST</td><td>HOLY CROSS [REDACTED] FL (HCFL) HOSPITAL LAB</td><td ID="Result.1.2.840.114350.1.13.502.2.7.2.798268.1291111714.Comp20Signature"/></tr><tr ID="Result.1.2.840.114350.1.13.502.2.7.2.798268.1291111714.Comp21" class="xRowNormal"><td ID="Result.1.2.840.114350.1.13.502.2.7.2.798268.1291111714.Comp21Name">NRBC</td><td>0.0</td><td>0.0 - 0.9 %</td><td><p>LAB HEMETOLOGY METHOD</p></td><td>[REDACTED] 10:01 AM EST</td><td>HOLY CROSS [REDACTED] FL (HCFL) HOSPITAL LAB</td><td ID="Result.1.2.840.114350.1.13.502.2.7.2.798268.1291111714.Comp21Signature"/></tr></tbody></table><table><colgroup><col width="20%" span="5"/></colgroup><thead><tr><th>Specimen (Source)</th><th>Anatomical Location / Laterality</th><th>Collection Method / Volume</th><th>Collection Time</th><th>Received Time</th></tr></thead><tbody><tr class="xRowNormal"><td ID="Result.1.2.840.114350.1.13.502.2.7.2.798268.1291111714.Specimen">Blood</td><td>Venous blood specimen / Unknown</td><td>Venipuncture / Unknown</td><td>[REDACTED]  9:10 AM EST</td><td>[REDACTED]  9:57 AM EST</td></tr></tbody></table><table><thead><tr><th>Narrative</th></tr></thead><tbody><tr><td class="xpre"><p/></td></tr></tbody></table><table><colgroup><col width="20%"/><col width="80%"/></colgroup><thead><tr><th>Authorizing Provider</th><th>Result Type</th></tr></thead><tbody><tr><td>[REDACTED] MD</td><td>LAB BLOOD ORDERABLES</td></tr></tbody></table><table><colgroup><col width="20%" span="3"/><col width="40%"/></colgroup><thead><tr><th>Performing Organization</th><th>Address</th><th>City/State/ZIP Code</th><th>Phone Number</th></tr></thead><tbody><tr><td ID="Result.1.2.840.114350.1.13.502.2.7.2.798268.1291111714.PerformingLab"><p>[REDACTED] (HCFL) HOSPITAL LAB</p></td><td><p>[REDACTED]</p></td><td><p>[REDACTED], US</p></td><td><p>[REDACTED]</p></td></tr></tbody></table></li><li>(ABNORMAL) Comprehensive metabolic panel ([REDACTED]  9:10 AM EST): <table><colgroup><col width="20%"/><col width="12%"/><col width="8%"/><col width="20%"/><col width="10%" span="2"/><col width="20%"/></colgroup><thead><tr><th>Component</th><th>Value</th><th>Ref Range</th><th>Test Method</th><th>Analysis Time</th><th>Performed At</th><th>Pathologist Signature</th></tr></thead><tbody><tr ID="Result.1.2.840.114350.1.13.502.2.7.2.798268.1291111712.Comp1" class="xRowNormal"><td ID="Result.1.2.840.114350.1.13.502.2.7.2.798268.1291111712.Comp1Name">Sodium</td><td>142</td><td>136 - 145 mmol/L</td><td><p>LAB CHEMISTRY METHOD</p></td><td>[REDACTED] 10:32 AM EST</td><td>HOLY CROSS [REDACTED] FL (HCFL) HOSPITAL LAB</td><td ID="Result.1.2.840.114350.1.13.502.2.7.2.798268.1291111712.Comp1Signature"/></tr><tr ID="Result.1.2.840.114350.1.13.502.2.7.2.798268.1291111712.Comp2" class="xRowAlt"><td ID="Result.1.2.840.114350.1.13.502.2.7.2.798268.1291111712.Comp2Name">Potassium</td><td>5.0</td><td>3.5 - 5.1 mmol/L</td><td><p>LAB CHEMISTRY METHOD</p></td><td>[REDACTED] 10:32 AM EST</td><td>HOLY CROSS [REDACTED] FL (HCFL) HOSPITAL LAB</td><td ID="Result.1.2.840.114350.1.13.502.2.7.2.798268.1291111712.Comp2Signature"/></tr><tr ID="Result.1.2.840.114350.1.13.502.2.7.2.798268.1291111712.Comp3" class="xRowNormal"><td ID="Result.1.2.840.114350.1.13.502.2.7.2.798268.1291111712.Comp3Name">Chloride</td><td><span class="xflagData">108</span><span class="xflagData"> (H)</span></td><td>98 - 107 mmol/L</td><td><p>LAB CHEMISTRY METHOD</p></td><td>[REDACTED] 10:32 AM EST</td><td>HOLY CROSS [REDACTED] FL (HCFL) HOSPITAL LAB</td><td ID="Result.1.2.840.114350.1.13.502.2.7.2.798268.1291111712.Comp3Signature"/></tr><tr ID="Result.1.2.840.114350.1.13.502.2.7.2.798268.1291111712.Comp4" class="xRowAlt"><td ID="Result.1.2.840.114350.1.13.502.2.7.2.798268.1291111712.Comp4Name">CO2</td><td>28</td><td>21 - 31 mmol/L</td><td><p>LAB CHEMISTRY METHOD</p></td><td>[REDACTED] 10:32 AM EST</td><td>HOLY CROSS [REDACTED] FL (HCFL) HOSPITAL LAB</td><td ID="Result.1.2.840.114350.1.13.502.2.7.2.798268.1291111712.Comp4Signature"/></tr><tr ID="Result.1.2.840.114350.1.13.502.2.7.2.798268.1291111712.Comp5" class="xRowNormal"><td ID="Result.1.2.840.114350.1.13.502.2.7.2.798268.1291111712.Comp5Name">Anion Gap</td><td>6</td><td>5 - 15</td><td><p>LAB CHEMISTRY METHOD</p></td><td>[REDACTED] 10:32 AM EST</td><td>HOLY CROSS [REDACTED] FL (HCFL) HOSPITAL LAB</td><td ID="Result.1.2.840.114350.1.13.502.2.7.2.798268.1291111712.Comp5Signature"/></tr><tr ID="Result.1.2.840.114350.1.13.502.2.7.2.798268.1291111712.Comp6" class="xRowAlt"><td ID="Result.1.2.840.114350.1.13.502.2.7.2.798268.1291111712.Comp6Name">Glucose</td><td><span class="xflagData">113</span><span class="xflagData"> (H)</span></td><td>74 - 109 mg/dL</td><td><p>LAB CHEMISTRY METHOD</p></td><td>[REDACTED] 10:32 AM EST</td><td>HOLY CROSS [REDACTED] FL (HCFL) HOSPITAL LAB</td><td ID="Result.1.2.840.114350.1.13.502.2.7.2.798268.1291111712.Comp6Signature"/></tr><tr ID="Result.1.2.840.114350.1.13.502.2.7.2.798268.1291111712.Comp7" class="xRowNormal"><td ID="Result.1.2.840.114350.1.13.502.2.7.2.798268.1291111712.Comp7Name">BUN</td><td>19</td><td>7 - 25 mg/dL</td><td><p>LAB CHEMISTRY METHOD</p></td><td>[REDACTED] 10:32 AM EST</td><td>HOLY CROSS [REDACTED] FL (HCFL) HOSPITAL LAB</td><td ID="Result.1.2.840.114350.1.13.502.2.7.2.798268.1291111712.Comp7Signature"/></tr><tr ID="Result.1.2.840.114350.1.13.502.2.7.2.798268.1291111712.Comp8" class="xRowAlt"><td ID="Result.1.2.840.114350.1.13.502.2.7.2.798268.1291111712.Comp8Name">Creatinine</td><td><span class="xflagData">0.36</span><span class="xflagData"> (L)</span></td><td>0.70 - 1.30 mg/dL</td><td><p>LAB CHEMISTRY METHOD</p></td><td>[REDACTED] 10:32 AM EST</td><td>HOLY CROSS [REDACTED] FL (HCFL) HOSPITAL LAB</td><td ID="Result.1.2.840.114350.1.13.502.2.7.2.798268.1291111712.Comp8Signature"/></tr><tr ID="Result.1.2.840.114350.1.13.502.2.7.2.798268.1291111712.Comp9" class="xRowNormal"><td ID="Result.1.2.840.114350.1.13.502.2.7.2.798268.1291111712.Comp9Name">eGFR</td><td><span class="content_span">117</span></td><td>&gt;=60 mL/min/1.73m2</td><td><p>LAB CHEMISTRY METHOD</p></td><td>[REDACTED] 10:32 AM EST</td><td>HOLY CROSS [REDACTED] FL (HCFL) HOSPITAL LAB</td><td ID="Result.1.2.840.114350.1.13.502.2.7.2.798268.1291111712.Comp9Signature"/></tr><tr class="xRowNormal xmergeUp"><td colspan="7"><content class="xallIndent"><span class="xcellHeader">Comment: </span><br/><content class="xpre">Calculation based on the Chronic Kidney Disease Epidemiology Collaboration (CKD-EPI) equation refit without adjustment for race.<br/>GFR less than 60 (mL/min/1.73 mm2) may indicate chronic kidney disease.<br/></content></content></td></tr><tr ID="Result.1.2.840.114350.1.13.502.2.7.2.798268.1291111712.Comp10" class="xRowAlt"><td ID="Result.1.2.840.114350.1.13.502.2.7.2.798268.1291111712.Comp10Name">BUN/Creatinine Ratio</td><td><span class="xflagData">52.8</span><span class="xflagData"> (H)</span></td><td>6.0 - 20.0</td><td><p>LAB CHEMISTRY METHOD</p></td><td>[REDACTED] 10:32 AM EST</td><td>HOLY CROSS FORT LAUDERDALE FL (HCFL) HOSPITAL LAB</td><td ID="Result.1.2.840.114350.1.13.502.2.7.2.798268.1291111712.Comp10Signature"/></tr><tr ID="Result.1.2.840.114350.1.13.502.2.7.2.798268.1291111712.Comp11" class="xRowNormal"><td ID="Result.1.2.840.114350.1.13.502.2.7.2.798268.1291111712.Comp11Name">Calcium</td><td>9.7</td><td>8.6 - 10.3 mg/dL</td><td><p>LAB CHEMISTRY METHOD</p></td><td>[REDACTED] 10:32 AM EST</td><td>[REDACTED] FL (HCFL) HOSPITAL LAB</td><td ID="Result.1.2.840.114350.1.13.502.2.7.2.798268.1291111712.Comp11Signature"/></tr><tr ID="Result.1.2.840.114350.1.13.502.2.7.2.798268.1291111712.Comp12" class="xRowAlt"><td ID="Result.1.2.840.114350.1.13.502.2.7.2.798268.1291111712.Comp12Name">AST (SGOT)</td><td>26</td><td>13 - 39 unit/L</td><td><p>LAB CHEMISTRY METHOD</p></td><td>[REDACTED] 10:32 AM EST</td><td>HOLY CROSS [REDACTED] FL (HCFL) HOSPITAL LAB</td><td ID="Result.1.2.840.114350.1.13.502.2.7.2.798268.1291111712.Comp12Signature"/></tr><tr ID="Result.1.2.840.114350.1.13.502.2.7.2.798268.1291111712.Comp13" class="xRowNormal"><td ID="Result.1.2.840.114350.1.13.502.2.7.2.798268.1291111712.Comp13Name">ALT (SGPT)</td><td>33</td><td>7 - 52 unit/L</td><td><p>LAB CHEMISTRY METHOD</p></td><td>[REDACTED] 10:32 AM EST</td><td>HOLY CROSS [REDACTED] FL (HCFL) HOSPITAL LAB</td><td ID="Result.1.2.840.114350.1.13.502.2.7.2.798268.1291111712.Comp13Signature"/></tr><tr ID="Result.1.2.840.114350.1.13.502.2.7.2.798268.1291111712.Comp14" class="xRowAlt"><td ID="Result.1.2.840.114350.1.13.502.2.7.2.798268.1291111712.Comp14Name">Alkaline Phosphatase</td><td>98</td><td>34 - 104 unit/L</td><td><p>LAB CHEMISTRY METHOD</p></td><td>[REDACTED] 10:32 AM EST</td><td>HOLY CROSS [REDACTED] FL (HCFL) HOSPITAL LAB</td><td ID="Result.1.2.840.114350.1.13.502.2.7.2.798268.1291111712.Comp14Signature"/></tr><tr ID="Result.1.2.840.114350.1.13.502.2.7.2.798268.1291111712.Comp15" class="xRowNormal"><td ID="Result.1.2.840.114350.1.13.502.2.7.2.798268.1291111712.Comp15Name">Total Protein</td><td>6.6</td><td>6.4 - 8.9 g/dL</td><td><p>LAB CHEMISTRY METHOD</p></td><td>[REDACTED] 10:32 AM EST</td><td>[REDACTED] FL (HCFL) HOSPITAL LAB</td><td ID="Result.1.2.840.114350.1.13.502.2.7.2.798268.1291111712.Comp15Signature"/></tr><tr ID="Result.1.2.840.114350.1.13.502.2.7.2.798268.1291111712.Comp16" class="xRowAlt"><td ID="Result.1.2.840.114350.1.13.502.2.7.2.798268.1291111712.Comp16Name">Globulin, Total</td><td>2.6</td><td>1.4 - 3.9 g/dL</td><td><p>LAB CHEMISTRY METHOD</p></td><td>[REDACTED] 10:32 AM EST</td><td>HOLY CROSS [REDACTED] FL (HCFL) HOSPITAL LAB</td><td ID="Result.1.2.840.114350.1.13.502.2.7.2.798268.1291111712.Comp16Signature"/></tr><tr ID="Result.1.2.840.114350.1.13.502.2.7.2.798268.1291111712.Comp17" class="xRowNormal"><td ID="Result.1.2.840.114350.1.13.502.2.7.2.798268.1291111712.Comp17Name">A/G Ratio</td><td>1.5</td><td>&gt;1.0</td><td><p>LAB CHEMISTRY METHOD</p></td><td>[REDACTED] 10:32 AM EST</td><td>HOLY CROSS [REDACTED] FL (HCFL) HOSPITAL LAB</td><td ID="Result.1.2.840.114350.1.13.502.2.7.2.798268.1291111712.Comp17Signature"/></tr><tr ID="Result.1.2.840.114350.1.13.502.2.7.2.798268.1291111712.Comp18" class="xRowAlt"><td ID="Result.1.2.840.114350.1.13.502.2.7.2.798268.1291111712.Comp18Name">Total Bilirubin</td><td>0.3</td><td>0.3 - 1.0 mg/dL</td><td><p>LAB CHEMISTRY METHOD</p></td><td>[REDACTED] 10:32 AM EST</td><td>HOLY CROSS [REDACTED] FL (HCFL) HOSPITAL LAB</td><td ID="Result.1.2.840.114350.1.13.502.2.7.2.798268.1291111712.Comp18Signature"/></tr><tr ID="Result.1.2.840.114350.1.13.502.2.7.2.798268.1291111712.Comp19" class="xRowNormal"><td ID="Result.1.2.840.114350.1.13.502.2.7.2.798268.1291111712.Comp19Name">Albumin</td><td>4.0</td><td>3.5 - 5.7 g/dL</td><td><p>LAB CHEMISTRY METHOD</p></td><td>[REDACTED] 10:32 AM EST</td><td>HOLY CROSS [REDACTED] FL (HCFL) HOSPITAL LAB</td><td ID="Result.1.2.840.114350.1.13.502.2.7.2.798268.1291111712.Comp19Signature"/></tr></tbody></table><table><colgroup><col width="20%" span="5"/></colgroup><thead><tr><th>Specimen (Source)</th><th>Anatomical Location / Laterality</th><th>Collection Method / Volume</th><th>Collection Time</th><th>Received Time</th></tr></thead><tbody><tr class="xRowNormal"><td ID="Result.1.2.840.114350.1.13.502.2.7.2.798268.1291111712.Specimen">Blood</td><td>Venous blood specimen / Unknown</td><td>Venipuncture / Unknown</td><td>[REDACTED]  9:10 AM EST</td><td>[REDACTED]  9:57 AM EST</td></tr></tbody></table><table><thead><tr><th>Narrative</th></tr></thead><tbody><tr><td class="xpre"><p/></td></tr></tbody></table><table><colgroup><col width="20%"/><col width="80%"/></colgroup><thead><tr><th>Authorizing Provider</th><th>Result Type</th></tr></thead><tbody><tr><td>[REDACTED] MD</td><td>LAB BLOOD ORDERABLES</td></tr></tbody></table><table><colgroup><col width="20%" span="3"/><col width="40%"/></colgroup><thead><tr><th>Performing Organization</th><th>Address</th><th>City/State/ZIP Code</th><th>Phone Number</th></tr></thead><tbody><tr><td ID="Result.1.2.840.114350.1.13.502.2.7.2.798268.1291111712.PerformingLab"><p>[REDACTED] FL (HCFL) HOSPITAL LAB</p></td><td><p>[REDACTED]</p></td><td><p>[REDACTED], US</p></td><td><p>[REDACTED]</p></td></tr></tbody></table></li><li>(ABNORMAL) Testosterone, total ([REDACTED]  9:10 AM EST): <table><colgroup><col width="20%"/><col width="12%"/><col width="8%"/><col width="20%"/><col width="10%" span="2"/><col width="20%"/></colgroup><thead><tr><th>Component</th><th>Value</th><th>Ref Range</th><th>Test Method</th><th>Analysis Time</th><th>Performed At</th><th>Pathologist Signature</th></tr></thead><tbody><tr ID="Result.1.2.840.114350.1.13.502.2.7.2.798268.1291111711.Comp1" class="xRowNormal"><td ID="Result.1.2.840.114350.1.13.502.2.7.2.798268.1291111711.Comp1Name">Testosterone</td><td><span class="xflagData">80</span><span class="xflagData"> (L)</span></td><td>175 - 781 ng/dL</td><td><p>LAB CHEMISTRY METHOD</p></td><td>[REDACTED] 10:43 AM EST</td><td>HOLY CROSS [REDACTED] FL (HCFL) HOSPITAL LAB</td><td ID="Result.1.2.840.114350.1.13.502.2.7.2.798268.1291111711.Comp1Signature"/></tr></tbody></table><table><colgroup><col width="20%" span="5"/></colgroup><thead><tr><th>Specimen (Source)</th><th>Anatomical Location / Laterality</th><th>Collection Method / Volume</th><th>Collection Time</th><th>Received Time</th></tr></thead><tbody><tr class="xRowNormal"><td ID="Result.1.2.840.114350.1.13.502.2.7.2.798268.1291111711.Specimen">Blood</td><td>Venous blood specimen / Unknown</td><td>Venipuncture / Unknown</td><td>[REDACTED]  9:10 AM EST</td><td>[REDACTED] 10:08 AM EST</td></tr></tbody></table><table><thead><tr><th>Narrative</th></tr></thead><tbody><tr><td class="xpre"><p>HOLY CROSS [REDACTED] FL (HCFL) HOSPITAL LAB - [REDACTED] 10:43 AM EST</p><p><span class="content_span">According to the reagent manufacturer, consumption of biotin supplements, or multivitamins containing biotin, may interfere with the results of this assay. For individuals taking biotin containing supplements, testing at least three days after cessation of supplement consumption is recommended.</span></p></td></tr></tbody></table><table><colgroup><col width="20%"/><col width="80%"/></colgroup><thead><tr><th>Authorizing Provider</th><th>Result Type</th></tr></thead><tbody><tr><td>[REDACTED] MD</td><td>LAB BLOOD ORDERABLES</td></tr></tbody></table><table><colgroup><col width="20%" span="3"/><col width="40%"/></colgroup><thead><tr><th>Performing Organization</th><th>Address</th><th>City/State/ZIP Code</th><th>Phone Number</th></tr></thead><tbody><tr><td ID="Result.1.2.840.114350.1.13.502.2.7.2.798268.1291111711.PerformingLab"><p>[REDACTED] (HCFL) HOSPITAL LAB</p></td><td><p>[REDACTED]</p></td><td><p>[REDACTED], [REDACTED]</p></td><td><p>[REDACTED]</p></td></tr></tbody></table></li><li>(ABNORMAL) Prostate specific antigen, total and free ([REDACTED]  9:10 AM EST): <table><colgroup><col width="20%"/><col width="12%"/><col width="8%"/><col width="20%"/><col width="10%" span="2"/><col width="20%"/></colgroup><thead><tr><th>Component</th><th>Value</th><th>Ref Range</th><th>Test Method</th><th>Analysis Time</th><th>Performed At</th><th>Pathologist Signature</th></tr></thead><tbody><tr ID="Result.1.2.840.114350.1.13.502.2.7.2.798268.1291111710.Comp1" class="xRowNormal"><td ID="Result.1.2.840.114350.1.13.502.2.7.2.798268.1291111710.Comp1Name">PSA</td><td>0.01</td><td>0.00 - 4.00 ng/mL</td><td><p>LAB CHEMISTRY METHOD</p></td><td>[REDACTED] 10:49 AM EST</td><td>HOLY CROSS [REDACTED] FL (HCFL) HOSPITAL LAB</td><td ID="Result.1.2.840.114350.1.13.502.2.7.2.798268.1291111710.Comp1Signature"/></tr><tr ID="Result.1.2.840.114350.1.13.502.2.7.2.798268.1291111710.Comp2" class="xRowAlt"><td ID="Result.1.2.840.114350.1.13.502.2.7.2.798268.1291111710.Comp2Name">PSA, Free</td><td><span class="xflagData">0.01</span><span class="xflagData"> (L)</span></td><td>0.20 - 4.90 ng/mL</td><td><p>LAB CHEMISTRY METHOD</p></td><td>[REDACTED] 10:49 AM EST</td><td>HOLY CROSS [REDACTED] FL (HCFL) HOSPITAL LAB</td><td ID="Result.1.2.840.114350.1.13.502.2.7.2.798268.1291111710.Comp2Signature"/></tr><tr ID="Result.1.2.840.114350.1.13.502.2.7.2.798268.1291111710.Comp3" class="xRowNormal"><td ID="Result.1.2.840.114350.1.13.502.2.7.2.798268.1291111710.Comp3Name">PSA, Free Pct</td><td>100.0</td><td>See Comment %</td><td><p>LAB CHEMISTRY METHOD</p></td><td>[REDACTED] 10:49 AM EST</td><td>HOLY CROSS [REDACTED] FL (HCFL) HOSPITAL LAB</td><td ID="Result.1.2.840.114350.1.13.502.2.7.2.798268.1291111710.Comp3Signature"/></tr></tbody></table><table><colgroup><col width="20%" span="5"/></colgroup><thead><tr><th>Specimen (Source)</th><th>Anatomical Location / Laterality</th><th>Collection Method / Volume</th><th>Collection Time</th><th>Received Time</th></tr></thead><tbody><tr class="xRowNormal"><td ID="Result.1.2.840.114350.1.13.502.2.7.2.798268.1291111710.Specimen">Blood</td><td>Venous blood specimen / Unknown</td><td>Venipuncture / Unknown</td><td>[REDACTED]  9:10 AM EST</td><td>[REDACTED] 10:08 AM EST</td></tr></tbody></table><table><thead><tr><th>Narrative</th></tr></thead><tbody><tr><td class="xpre"><p>HOLY CROSS [REDACTED] FL (HCFL) HOSPITAL LAB - [REDACTED] 10:49 AM EST</p><p><span class="content_span">According to the reagent manufacturer, consumption of biotin supplements, or multivitamins containing biotin, may interfere with the results of this assay. For individuals taking biotin containing supplements, testing at least three days after cessation of supplement consumption is recommended.</span><br/><span class="content_span"> </span><br/><span class="content_span">See table below for probability of Prostate Cancer (patients with negative DRE). Parentheses indicate 95% Confidence Intervals in %.</span><br/><span class="content_span"> </span><br/><span class="content_span">            %Free           Age Group (Years)           All</span><br/><span class="content_span">             PSA        [REDACTED][REDACTED][REDACTED][REDACTED][REDACTED]     [REDACTED]+        Ages </span><br/><span class="content_span">___________________________________________________</span><br/><span class="content_span"> PSA        &lt;=10%       45.3%      59.0%      70.3%     55.4%</span><br/><span class="content_span">4.0-10.0  (33.8-57.3)(46.5-68.9)(53.0-84.1)(48.1-62.6)</span><br/><span class="content_span"> ng/mL</span><br/><span class="content_span">           11-19%       22.5%      30.3%      38.0%     29.4%</span><br/><span class="content_span">                     (15.1-31.4)(23.6-37.7)(26.7-50.3)(24.7-34.4)</span><br/><span class="content_span"> </span><br/><span class="content_span">           &gt;=20%         0.0%      25.0%      28.3%     24.2%</span><br/><span class="content_span">                         N/A    (12.7-41.2)(16.0-43.5)(16.0-34.1)</span><br/><span class="content_span">___________________________________________________</span><br/><span class="content_span"> </span><br/><span class="content_span">The diagnostic usefulness of % Free PSA has not been established in patients with Total PSA below 2.6 ng/mL.</span><br/><span class="content_span"> </span><br/><span class="content_span">In men with PSA values above 10 ng/mL, prostate cancer risk is determined by Total PSA alone.</span><br/><span class="content_span"> </span><br/><span class="content_span">NCCN Guidelines Prostate Cancer Early Detection </span><br/><span class="content_span"> </span><br/><span class="content_span">Age(yrs)  DRE Finding         PSA Level </span><br/><span class="content_span">          Normal              &lt; 1  ng/mL    Repeat 2-4 year intervals </span><br/><span class="content_span">45-75     Normal              1 - 3 ng/mL   Repeat 1-2 year intervals </span><br/><span class="content_span">          Very Suspicious     &gt; 3  ng/mL    See indications for biopsy </span><br/><span class="content_span"> </span><br/><span class="content_span">&gt;75*      Normal              &lt; 4 ng/mL     Repeat 1-4 year intervals </span><br/><span class="content_span">                                           (if no other indications for biopsy) </span><br/><span class="content_span">          Very Suspicious     &gt;= 4 ng/mL    See indications for biopsy </span><br/><span class="content_span"> </span><br/><span class="content_span">* Testing men &gt;75 yrs should be done with caution and only in very healthy men with little or no comorbidity as a large proportion may harbor cancer that would be unlikely to affect their life expectancy. </span><br/><span class="content_span"> </span><br/><span class="content_span">Indications for Biopsy** </span><br/><span class="content_span">- Repeat PSA                   - Consider % Free PSA, </span><br/><span class="content_span">- DRE, if not                    4Kscore or PHI            - TRUS-guided biopsy </span><br/><span class="content_span">performed during          &gt;&gt;&gt;  - Consider             &gt;&gt;&gt;  - Follow up in 6-12 </span><br/><span class="content_span">initial risk assessment          multiparametric MRI         months with PSA/DRE </span><br/><span class="content_span">- Workup for benign disease </span><br/><span class="content_span"> </span><br/><span class="content_span">**The level of PSA correlates with the risk of prostate cancer. The Prostate Cancer Prevention Trial (PCPT) demonstrated that 15% of men with a PSA level of &lt;=4.0 ng/mL and a normal DRE had prostate cancer diagnosed on end-of-study biopsies. Approximately 30% to 35% of men with serum PSA between 4 to 10 ng/mL will be found to have cancer. Total PSA levels &gt;10 ng/[REDACTED] a greater than 67% likelihood of prostate cancer. </span><br/><span class="content_span"> </span><br/><span class="content_span">Based on the National Comprehensive Cancer Network (NCCN) Guidelines </span><br/><span class="content_span">Version 2.2018 Prostate Cancer Early Detection. </span></p></td></tr></tbody></table><table><colgroup><col width="20%"/><col width="80%"/></colgroup><thead><tr><th>Authorizing Provider</th><th>Result Type</th></tr></thead><tbody><tr><td>[REDACTED] MD</td><td>LAB BLOOD ORDERABLES</td></tr></tbody></table><table><colgroup><col width="20%" span="3"/><col width="40%"/></colgroup><thead><tr><th>Performing Organization</th><th>Address</th><th>City/State/ZIP Code</th><th>Phone Number</th></tr></thead><tbody><tr><td ID="Result.1.2.840.114350.1.13.502.2.7.2.798268.1291111710.PerformingLab"><p>[REDACTED] FL (HCFL) HOSPITAL LAB</p></td><td><p>[REDACTED]</p></td><td><p>[REDACTED], [REDACTED]</p></td><td><p>[REDACTED]</p></td></tr></tbody></table></li></ul>documented in this encounter</div><h3><a name="id9" href="#toc">Visit Diagnoses</a></h3><div><table><colgroup><col width="100%"/></colgroup><thead><tr><th>Diagnosis</th></tr></thead><tbody><tr ID="vdx4" class="xRowNormal"><td><p><span class="content_span">Malignant neoplasm of prostate (CMS/HCC)</span><span class="content_span"> - Primary</span></p><p>Malignant neoplasm of prostate</p></td></tr><tr ID="vdx5" class="xRowAlt"><td><p><span class="content_span">History of muscular dystrophy</span></p></td></tr></tbody></table>documented in this encounter</div><h3><a name="id10" href="#toc">Additional Health Concerns</a></h3><div><table><colgroup><col width="50%" span="2"/></colgroup><thead><tr><th>Assessment</th><th>Noted Time</th></tr></thead><tbody><tr class="xRowNormal"><td ID="assessment1">PHQ-9 Depression Total Score: 0</td><td>[REDACTED] 10:41 AM EDT</td></tr><tr class="xRowAlt"><td ID="assessment2">A fall risk assessment has been completed for the patient</td><td>[REDACTED] 10:41 AM EDT</td></tr></tbody></table>documented as of this encounter</div><h3><a name="id11" href="#toc">Care Teams</a></h3><div><table ID="ct52"><colgroup><col width="25%" span="3"/><col width="13%"/><col width="12%"/></colgroup><thead><tr><th>Team Member</th><th>Relationship</th><th>Specialty</th><th>Start Date</th><th>End Date</th></tr></thead><tbody><tr class="xRowNormal"><td><p>[REDACTED], DO</p><p>NPI: [REDACTED]</p><p>[REDACTED]</p><p>[REDACTED]-2828</p><p>[REDACTED] (Work)</p><p>[REDACTED] (Fax)</p></td><td>PCP - General</td><td>Internal Medicine</td><td>[REDACTED]</td><td/></tr></tbody></table>documented as of this encounter</div><br/><br/>
</body></html>